Kim et al. developed a multi-staged DDS based on DNA modification for deep penetrating cancer therapy [200]. The formulation combined acidic responsive size shrinkage and ligand exposure into one system. In detail, DOX was loaded on the G-C pairs of DNA duplexes (D1) and modified on the...